BRC News

More than 180,000 lives could be lost by 2030 unless urgent action is taken to fill critical gaps in breast cancer research, a report has warned. Image courtesy of Dr David Becker, Wellcome Images 

A team of researchers, including Professor Monty Mythen, has identified two predictors of short-term mortality that could help clinicians and patients to make better decisions about surgery.

The largest study of Middle East respiratory syndrome coronavirus (MERS-CoV) genomes, published in The Lancet today, reveals new information about how MERS-CoV is evolving, and its likely patterns of transmission.

BRC- sponsored ‘A’ level students have been celebrating their successful completion of summer lab placements.

The BRC, with funding from the Wellcome Trust, is inviting applications to a groundbreaking new Patient and Public Involvement (PPI) bursary fund.

The BRC has just awarded over £5 million to 6 high impact experimental medicine initiatives.

UCL has been shortlisted for the International Collaboration of the Year award at the Times Higher Education Awards 2013.

BRC Director Professor Bryan Williams has been appointed as a board member of the National Institute for Health Research (NIHR) Strategy Board.

Researchers at the Medical Research Council (MRC) have developed and tested a more efficient and cost effective way to diagnose early onset, genetic forms of dementia. Image courtesy of Neil Webb, Wellcome Images

UCLH and UCL are major partners in a successful bid for £9m for applied health research in the NHS.

The National Institute for Health Research (NIHR) has launched a focus on dementia research initiative to mark World Alzheimer’s Month.

The Macmillan Cancer Centre, part of University College London Hospitals NHS Foundation Trust, is celebrating the one year anniversary of the installation of the UK’s first fully integrated MR and PET scanner.

The BRC has featured in a new guide for the bioscience industry published by the National Institute for Health Research Office for Clinical Research Infrastructure (NOCRI) and the BioIndustry Association (BIA).

Researchers have discovered how genetic mutations linked to Parkinsons’s disease may be key to the brain cell death associated with the disease, paving the way for developing more effective drug treatments.

Two BRC-supported professors are to lead themes in the National Institute of Health Research’s new Rare Diseases Translational Research Collaboration. Image courtesy of Wellcome Images